Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors
Influenza A virus (IAV) matrix protein 2 (M2), an ion channel, is crucial for virus infection, and therefore, an important anti-influenza drug target. Adamantanes, also known as M2 channel blockers, are one of the two classes of Food and Drug Administration-approved anti-influenza drugs, although th...
Main Authors: | Draginja Radosevic, Milan Sencanski, Vladimir Perovic, Nevena Veljkovic, Jelena Prljic, Veljko Veljkovic, Emily Mantlo, Natalya Bukreyeva, Slobodan Paessler, Sanja Glisic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcimb.2019.00067/full |
Similar Items
-
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel <i>In Silico</i> Method
by: Milan Sencanski, et al.
Published: (2020-08-01) -
In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease [v1; ref status: indexed, http://f1000r.es/5bs]
by: Veljko Veljkovic, et al.
Published: (2015-05-01) -
Evolution of 2014/15 H3N2 influenza viruses circulating in US: consequences for vaccine effectiveness and possible new pandemic
by: Veljko eVeljkovic, et al.
Published: (2015-12-01) -
Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection [version 2; referees: 2 approved]
by: Veljko Veljkovic, et al.
Published: (2016-03-01) -
Repurposing of Drug Candidates for Treatment of Skin Cancer
by: Hernán Cortés, et al.
Published: (2021-01-01)